← Insider buys
KALV

KalVista Pharmaceuticals, Inc. · Healthcare

Chief Scientific Officer Edward P. Feener sold $123K of KalVista Pharmaceuticals, Inc.

Sold$123,134
$20.52Price
6,000Shares
−42%Stake

What KALV did after the filing

Prices for KALV after this filing aren't in yet.

Traded Mon, Aug 2. Filed Wed, Aug 4, 3:55 PM ET, during the session. Not investment advice.